Fig. 5
From: Phage-antibiotic synergy reduces Burkholderia cenocepacia population
Effect of PAS on B. cenocepacia K56-2 growth in ASMDM over time. Bacterial cells suspended in 60% ASMDM were treated with PAS, phage, or trimethoprim at two doses. A) Treatment with high dose of trimethoprim (0.88 mg/well). N = 4. B) Treatment with low dose of trimethoprim (0.0088 mg/well). N = 3. B. cenocepacia K56-2 no treatment (circle), PAS treatment (diamond), trimethoprim (square), KP1 phage (triangle). MOI = 17. Values are mean ± standard deviation. Statistical analysis was performed with MANOVA, P < .05. The PAS treatments are significantly different from the untreated K56-2 and K56-2 treated with phage or trimethoprim